|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue | |||||
| Collaborative arrangement revenue | |||||
| Total revenue | |||||
| Operating expenses | |||||
| Research and development | |||||
| Collaborative arrangement revenue | |||||
| Total research and development | |||||
| General and administrative | |||||
| Total operating expenses | |||||
| Loss from operations | |||||
| Other (expense) income : | |||||
| Interest income | |||||
| Interest expense | |||||
| Other (expense) income, net | |||||
| Total other (expense) income | |||||
| Loss before income taxes | |||||
| Income tax benefit | |||||
| Net loss | |||||
| Other comprehensive income | |||||
| Foreign currency translation adjustment | |||||
| Unrealized gain (loss) on marketable securities | |||||
| Comprehensive loss | |||||
| Net loss attributable to shareholders - basic | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total net loss attributable to shareholders - basic | |||||
| Net loss attributable to shareholders - diluted | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total net loss attributable to shareholders - diluted | |||||
| Weighted shares used in calculating net loss per share - basic (in shares) | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total weighted shares used in calculating net loss per share - basic (in shares) | |||||
| Weighted shares used in calculating net loss per share - diluted (in shares) | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total weighted shares used in calculating net loss per share - diluted (in shares) | |||||
| Net loss per share attributable to shareholders - basic (in USD per share) | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total net loss per share attributable to shareholders - basic (in USD per share) | |||||
| Net loss per share attributable to shareholders - diluted (in USD per share) | |||||
| Common Stock | |||||
| Series B Convertible Preferred Stock | |||||
| Total net loss per share attributable to shareholders - diluted (in USD per share) | |||||
Loading...